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Abstract
Background: Preimplantation genetic screening (PGS) provides an opportunity to eliminate a potential
implantation failure due to aneuploidy in infertile couples. Some studies clearly show that twins following single
embryo transfer (SET) can be the result of a concurrent natural conception and an incidence as high as 1 in 5 twins
has been reported.
In our case PGS was performed on trophectoderm (TE) biopsies by quantitative polymerase chain reaction (qPCR).
The product of conception (POC) was cytogenetically investigated after selection of the placental villi by means
of the direct method. Molecular cytogenetic characterization of the POC was performed by fluorescence in situ
hybridization (FISH) and array-comparative genomic hybridization (a-CGH) analyses. To investigate the possibility of
a spontaneous conception, a panel of 40 single nucleotide polymorphisms (SNPs) was used to compare genetic
similarity between the DNA of the POC and the DNA leftover of the TE biopsy.
Findings: We describe a 36-year old infertile woman undergoing PGS who had a spontaneous abortion after a
single euploid embryo transfer on a spontaneous cycle. The POC showed a 45,X karyotype confirmed by FISH
and a-CGH. DNA fingerprinting demonstrated a genetic similarity of 75 % between the DNA of the POC and TE
biopsy, consistent with a sibling status. All supernumerary euploid embryos were also tested showing a non-self
relationship with the POC, excluding a mix-up event at the time of fetal embryo transfer.
Conclusions: DNA fingerprinting of the transferred blastocyst and POC, confirmed the occurrence of a
spontaneous conception. This case challenges the assumption that a pregnancy after assisted reproductive
technology (ART) is always a result of ART, and strengthens the importance to avoid intercourses during PGS
and natural transfer cycles. Moreover, cytogenetic analysis of the POCs is strongly recommended along with
fingerprinting children born after PGS to see what the concordance is between the embryo transferred and the
resultant child.
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Introduction
PGS is an early method to detect aneuploidies in preim-
plantation embryos. PGS can be offered to patients with
an increased risk of having a higher percentage of chro-
mosomally abnormal embryos, improving the reproduct-
ive outcome. By transferring only chromosomally normal
embryos the miscarriage rates are expected to be lower,
since about 60–70 % of miscarriages in the first trimester
result from chromosomal abnormalities in the fetus [1].
Some studies clearly show that twins following SET can
be the result of a concurrent natural conception [2, 3] and
an incidence as high as 1 in 5 twins has been reported [4].
We describe a rare case of a 36-year-old infertile patient
with recurrent implantation failures. PGS was performed
and an euploid blastocyst transferred. However, a spon-
taneous abortion occurred after 13 weeks of gestation,
ascertained to be 10 at ultrasound examination. Cytogen-
etic analysis revealed a 45,X karyotype. DNA fingerprint-
ing analysis of POC and the euploid embryo transferred
excluded a self-relationship confirming the occurrence of
a spontaneous conception in concomitance with SET.
Materials and methods
A 36-year old woman experiencing 6 years infertility
with a diagnosis of severe endometriosis was referred to
Humanitas Fertility Center. She had a miscarriage at
8 weeks after an intrauterine insemination (IUI), other 2
negative IUI cycles and 3 negative in vitro fertilization
(IVF) cycles with the transfer of 11 cleavage stage
embryos from fresh and frozen cycles performed in
other centers. A normal uterine cavity was confirmed at
hysteroscopy while a transvaginal ultrasound imaging
showed a 18 mm small endometrial cyst of the right
ovary and 12 mm recto-vaginal lesion. Despite a high
follicle-stimulating hormone (FSH) level of 14 IU/L,
ovarian reserve assessed to be normal with an anti-
Müllerian hormone (AMH) level of 3.8 ng/ml and the
existence of 10 antral follicles. Her partner sperm ana-
lysis showed 12 million total motile sperm with 2 % nor-
mal forms and 80 % vitality. After counseling and
obtaining informed consent, the patient was enrolled for
a first attempt intracytoplasmic sperm injection (ICSI)
with PGS cycle. Controlled ovarian hyper-stimulation
was started with 225 IU recombinant FSH (rFSH) in
a gonadotropin-releasing hormone (GnRH) antagonist
analog cycle. Recombinant human chorionic gonadotropin
(rhCG) (250 mcg) was administered on day 13 of the
induction cycle after a total rFSH dose of 3325 IU.
A transvaginal ultrasound guided under deep sedation
oocyte retrieval was performed 36 h after the rhCG trig-
ger and 9 metaphase II oocytes were retrieved. In 8
metaphase II oocytes ICSI was performed and placed in
an incubator with an integrated time-lapse system,
where the embryos were cultured individually in 25 μl
microwells and monitored for 24 h. At 16–18 h post-
ICSI, the 8 oocytes were assessed for the presence of 2
pronuclei and cultured until blastocyst stage. Three
expanded blastocysts underwent biopsy of TE cells day 5
and 4 day 6 as previously described [5], 1 embryo degen-
erated after development to morula. Blastocyst quality
was assessed immediately before TE biopsy [6], and blas-
tocysts vitrified according to the protocol described by
Kuwayama et al. [7]. Of the 7 biopsied and cryo-
preserved blastocysts, 4 were euploid. TE biopsies were
analysed by qPCR based comprehensive chromosome
diagnosis [8, 9]. This method has been extensively
validated for chromosome copy number analysis of TE
biopsies in preclinical [8, 9] and clinical studies [10, 11]
and was reported to have a recognizable error rate of
0.2 % in clinical pregnancies [12].
The embryo transfer was scheduled on a spontaneous
cycle. The patient was monitored from day 6 of the cycle
by ultrasound and a urinary luteinizing hormone (LH)
kit. On cycle day 15 an endometrial thickness of
12.2 mm with 2 follicles of 18 and 22 mm were observed
with a positive LH determination. Seven days after LH
surge a single euploid blastocyst (embryo number 3) was
selected for transfer based on morphological score,
warmed and cultured at 37 °C until transfer, performed
under ultrasound guidance.
A positive hCG determination was performed 14 days
after the embryo transfer (1765 IU) and a 6 weeks ultra-
sound showed an intrauterine gestation with an embryo
with normal fetal heart rate.
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Table 1 Genotyping data of 40 SNPs in technical duplicates
used to determine genetic similarity between the product of
conception and euploid IVF embryos. 1 and 2 represents the
two alleles for each SNP
Assay ID Villi gDNA Embryo 3 Embryo 6 Embryo 7
Assay01 11 11 22 11
Assay01 11 11 22 11
Assay02 22 unamplified 22 22
Assay02 22 unamplified 22 22
Assay03 11 11 11 11
Assay03 11 11 11 11
Assay04 11 11 11 12
Assay04 11 11 11 12
Assay05 12 22 12 12
Assay05 12 22 12 12
Assay06 22 22 12 22
Assay06 22 22 12 22
Assay07 12 11 11 12
Assay07 12 11 11 12
Assay08 22 22 22 22
Assay08 22 22 22 22
Assay09 12 unamplified 12 12
Assay09 12 unamplified 12 12
Assay10 12 11 11 11
Assay10 12 11 11 11
Assay11 11 12 12 11
Assay11 11 12 12 11
Assay12 12 12 12 12
Assay12 12 12 12 12
Assay13 11 11 11 11
Assay13 11 11 11 11
Assay14 22 11 22 12
Assay14 22 11 22 12
Assay15 22 22 12 12
Assay15 22 22 12 12
Assay16 12 12 11 22
Assay16 12 12 11 22
Assay17 12 12 11 12
Assay17 12 12 11 12
Assay18 12 12 12 12
Assay18 12 12 12 12
Assay19 12 12 22 12
Assay19 12 12 22 12
Assay20 11 11 11 11
Assay20 11 11 11 11
Table 1 Genotyping data of 40 SNPs in technical duplicates
used to determine genetic similarity between the product of
conception and euploid IVF embryos. 1 and 2 represents the
two alleles for each SNP (Continued)
Assay21 12 12 22 12
Assay21 12 12 22 12
Assay22 22 22 12 22
Assay22 22 22 12 22
Assay23 11 12 12 12
Assay23 11 12 12 12
Assay24 22 22 12 12
Assay24 22 22 12 12
Assay25 12 12 12 12
Assay25 12 12 12 12
Assay26 22 22 12 22
Assay26 22 22 12 22
Assay27 22 12 22 12
Assay27 22 12 22 12
Assay28 12 12 12 12
Assay28 12 12 12 12
Assay29 11 12 11 11
Assay29 11 12 11 11
Assay30 12 12 12 12
Assay30 12 12 12 12
Assay31 12 12 22 12
Assay31 12 12 22 12
Assay32 22 22 22 22
Assay32 22 22 22 22
Assay33 11 11 12 11
Assay33 11 11 12 11
Assay34 22 22 22 12
Assay34 22 22 22 12
Assay35 22 22 22 22
Assay35 22 22 22 22
Assay36 11 11 11 11
Assay36 11 11 11 11
Assay37 12 11 11 11
Assay37 12 11 11 11
Assay38 12 12 12 12
Assay38 12 12 12 12
Assay39 11 12 11 11
Assay39 11 12 11 11
Assay40 11 11 12 11
Assay40 11 11 12 11
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A diagnosis of internal abortion was performed at
13 weeks with a 10 weeks embryo development and after
the diagnosis the patients was submitted to aspiration
and curettage with selection of villous materials immedi-
ately sent to our Cytogenetic Laboratory.
Placental villi were then further selected under the
inverted microscope and cytogenetic analysis performed
by direct preparation after 24 h incubation [13]. This is
the method of choice in our laboratory because it avoids
the growth of normal cells from possible endometrial
contamination [1]. Parental karyotyping was performed
according to standard procedures.
FISH on 1000 interphase nuclei using Vysis CEPX
(DXZ1) Spectrum Green Probe (Abbott Molecular,
Abbott Park, Illinois, US), specific for chromosome X
centromere was conducted following the manufacturer’s
recommendations.
Array-CGH study was performed on the DNA ex-
tracted from uncultured villi using the QIAamp Mini Kit
(QIAGEN®, Hilden, Germany) and hybridized to the
SurePrint G3 Cancer CGH + SNP 4 × 180 K microarray
platform (Agilent Technologies, Santa Clara, CA, USA).
Data were analysed with Agilent CytoGenomics 3.0.1.1
software.
Since the couple did not abstain from having sexual
intercourses during the embryo transfer period, DNA
fingerprinting analysis of excess embryonic and POC
DNA was carried out to rule out the hypothesis of a
spontaneous conception rather than a false PGS negative
result. A set of 40 previously published SNPs with high
heterozygosity and low allele frequency variation were
utilized [14]. These SNPs were originally characterized
against ~2070 individuals from 40 populations. The
estimated probability that siblings will have identical
genotypes is 0.5 raised to the power of the number of
SNPs used, since all of these markers have alleles close
to 50:50 in the population. This technique has been vali-
dated by Scott and colleagues [15] as the first seamless
and inexpensive trophectoderm qPCR-based DNA fin-
gerprinting technology allowing the unequivocal dis-
crimination of sibling human embryos and foetuses.
Briefly, for either the multiplex amplification PCR prod-
uct residual from the TE biopsy or the purified genomic
DNA of the POC, real-time PCR for allelic discrimin-
ation was performed in duplicate reactions for each of
the individual 40 loci. Each reaction used the individual
TaqMan SNP Genotyping Assays, TaqMan Genotyping
Master Mix (Applied Biosystems Inc.), a 5 μl reaction
volume, a 384-well plate, and a Quant Studio sequence
detection system, as recommended by the supplier
(Applied Biosystems Inc.). Informative SNP genotypes
were compared between samples to determine the levels
of similarity and standard deviations from the mean
were calculated.
Results and discussion
The couple’s karyotype was normal. Cytogenetic analysis
on 20 Q-banded metaphases obtained from the POC
showed a 45,X karyotype. This result was confirmed by
FISH analysis showing one signal for CEPX in 94.9 % of
the nuclei. In 5.1 % of nuclei 2 signals were present,
probably due to a small maternal cell contamination that
is difficult to avoid in a POC sample even after placenta
villi selection. The 45,X karyotype observed in the meta-
phases obtained after 24 h of incubation excluded a mo-
saic karyotype in the embryo.
Array-CGH analysis performed on DNA from uncul-
tured villi confirmed chromosome X monosomy.
Allelic discrimination analysis of 40 SNPs of the excess
DNA from all the euploid blastocysts produced during
the present IVF cycle, revealed that none of them had a
genotype consistent with the POC. In particular, locus
dropout (no amplification of either allele) was observed
in only 4 assays of embryo number 3, with an overall call
rate of 97.5 % (156/160) (Table 1). All the euploid em-
bryos showed a similarity rate to POC below 80 %,
clearly consistent with a sibling genotype and a non-self-
relationship (Table 2). This analysis confirmed the
hypothesis of a spontaneous conception in the course of
the natural frozen embryo transfer cycle.
To our knowledge this the only case of PGS and
euploid SET resulted in a 45,X POC as consequence of a
natural pregnancy. A similar event has been reported in
a large study about twin births after SET where the
authors demonstrated that about 1 in 5 twins is due to a
concurrent spontaneous conception [4]. Another report
described a case of dizygotic twins of different-sex
delivered after SET demonstrated to be the consequence
of a natural fertilization [2].
Conclusions
Our case report demonstrates the occurrence of an
aneuploid spontaneous conception, resulted in a miscar-
riage, in the course of a natural SET cycle. This case
highlights the importance of avoiding intercourses and
natural transfer cycles for couples with reproductive
genetic risk, such as those undergoing preimplantation
genetic diagnosis (PGD)/PGS cycles, in order not only to
reduce the incidence of multiple pregnancies but espe-
cially to avoid the risk of aneuploid natural conceptions.
Table 2 Genetic similarity of the 3 euploid embryos obtained
during the IVF cycle with the genomic DNA from the
aneuploid POC
Sample ID Similarity to POC gDNA
Embryo 3 74 %
Embryo 6 55 %
Embryo 7 75 %
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Moreover, cytogenetic analysis of the POCs and finger-
printing of the children born after PGS are strongly
recommended.
Furthermore, with this study we confirm that parental
DNA information is not necessary since discrimination
was achieved based on a clear genotypic heterogeneity
among samples, without incorporating selection of in-
formative SNPs from parental genotype. Therefore, the
additional time and expense of evaluating parental DNA
could be avoided with this methodology as also previ-
ously reported [15].
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